Ally Bridge Group »

Ovid Therapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 1.8M 1.63

More positions owned by Ally Bridge Group

Replimune Group Call Option (REPL)
Edgewise Therapeutics (EWTX)
Abivax Sa Sponsored Ads (ABVX)
Soleno Therapeutics (SLNO)
Compass Pathways Sponsored Ads Call Option (CMPS)
Atai Beckley Nv SHS
Inventiva Sa Ads (IVA)
Minerva Neurosciences Com New (NERV)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Ovid Therapeutics (OVID)
Solid Biosciences Com New (SLDB)
Aadi Bioscience (WHWK)

View all positions for Ally Bridge Group

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
ADAR1 Capital Management
Vanguard Group
Affinity Asset Advisors
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management
Kennedy Capital Management
Ikarian Capital
Millennium Management
Schonfeld Strategic Advisors

View all funds holding Ovid Therapeutics